Results 211 to 220 of about 45,236 (264)

Identifying Aspirin as a Contributing Factor to Persistent Gout: A Case Report. [PDF]

Cureus
Nguyen J, Liang Y, Islam A, Kakarala V, Overturf MD.   +4 more
europepmc   +1 more source

High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis. [PDF]

J Biol Chem
Xu Z, Tang C, Song X, Liu Z, Zhou J, Shi Q, Yu C, Xu C.   +7 more
europepmc   +1 more source

Cardiovascular Events During Treatment With Xanthine Oxidoreductase Inhibitors in Patients With Gout and Hyperuricemia in Japan　- A JMDC Claims Database Study. [PDF]

Circ Rep
Kario K, Akari S, Kanegae H.
europepmc   +1 more source

Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout. [PDF]

J Manag Care Spec Pharm
Rizk JG, Qato DM, Bingham CO, dosReis S.
europepmc   +1 more source

The Promise of Dotinurad for Hyperuricemia in CKD. [PDF]

Kidney Int Rep
Li AS, Garimella PS.
europepmc   +1 more source

Scientific hypothesis generation by large language models: laboratory validation in breast cancer treatment. [PDF]

J R Soc Interface
Abdel-Rehim A, Zenil H, Orhobor O, Fisher M, Collins RJ, Bourne E, Fearnley GW, Tate E, Smith HX, Soldatova LN, King R.   +10 more
europepmc   +1 more source

Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy. [PDF]

Pharmaceuticals (Basel)
Asiri YI, Pichaivel M, Parameshwaran SP, Venkatesan K, Alqahtani S, Alqahtani T, Ahmed R, Elfadil H, Elodemi M, Genena S, Sivadasan D, Paulsamy P.   +11 more
europepmc   +1 more source

Evaluation of Xanthine Oxidase Inhibitors Febuxostat and Allopurinol on Kidney Dysfunction and Histological Damage in Two-Kidney, One-Clip (2K1C) Rats. [PDF]

Scientifica (Cairo)
Shuvo AUH, Alimullah M, Jahan I, Mitu KF, Rahman MJ, Akramuddaula K, Khan F, Dash PR, Subhan N, Alam MA.   +9 more
europepmc   +1 more source